Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
2.

Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.

Nellist M, Goedbloed MA, Halley DJ.

Biochem Soc Trans. 2003 Jun;31(Pt 3):587-91. Review.

PMID:
12773161
3.

Proteins interacting with the tuberous sclerosis gene products.

Rosner M, Freilinger A, Hengstschläger M.

Amino Acids. 2004 Oct;27(2):119-28. Review.

PMID:
15351877
4.

Tumour suppressors hamartin and tuberin: intracellular signalling.

Krymskaya VP.

Cell Signal. 2003 Aug;15(8):729-39. Review.

PMID:
12781866
5.

Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.

Kwiatkowski DJ.

Cancer Biol Ther. 2003 Sep-Oct;2(5):471-6. Review.

PMID:
14614311
6.

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Kwiatkowski DJ, Manning BD.

Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. Review.

7.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.

Astrinidis A, Henske EP.

Oncogene. 2005 Nov 14;24(50):7475-81. Review.

PMID:
16288294
8.

The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.

Rosner M, Hanneder M, Siegel N, Valli A, Hengstschläger M.

Mutat Res. 2008 Mar-Apr;658(3):234-46. doi: 10.1016/j.mrrev.2008.01.001. Review.

PMID:
18291711
9.

Tuberous sclerosis as an underlying basis for infantile spasm.

Yeung RS.

Int Rev Neurobiol. 2002;49:315-32. Review.

PMID:
12040899
10.

The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.

Nobukini T, Thomas G.

Novartis Found Symp. 2004;262:148-54; discussion 154-9, 265-8. Review.

PMID:
15562827
11.

Tuberous sclerosis: from tubers to mTOR.

Kwiatkowski DJ.

Ann Hum Genet. 2003 Jan;67(Pt 1):87-96. Review.

PMID:
12556239
12.

Tuberous sclerosis gene products in proliferation control.

Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M.

Mutat Res. 2001 Jul;488(3):233-9. Review.

PMID:
11397651
13.

Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.

Inoki K, Guan KL.

Hum Mol Genet. 2009 Apr 15;18(R1):R94-100. doi: 10.1093/hmg/ddp032. Review.

14.

MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.

Ronkina N, Menon MB, Schwermann J, Tiedje C, Hitti E, Kotlyarov A, Gaestel M.

Biochem Pharmacol. 2010 Dec 15;80(12):1915-20. doi: 10.1016/j.bcp.2010.06.021. Review.

PMID:
20599781
15.

Molecular genetic advances in tuberous sclerosis.

Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ.

Hum Genet. 2000 Aug;107(2):97-114. Review.

PMID:
11030407
16.

Rheb fills a GAP between TSC and TOR.

Manning BD, Cantley LC.

Trends Biochem Sci. 2003 Nov;28(11):573-6. Review.

PMID:
14607085
17.

Growth signaling: TSC takes its place.

Marygold SJ, Leevers SJ.

Curr Biol. 2002 Nov 19;12(22):R785-7. Review.

18.

sHsp-phosphorylation: enzymes, signaling pathways and functional implications.

Gaestel M.

Prog Mol Subcell Biol. 2002;28:151-69. Review. No abstract available.

PMID:
11908057
19.

14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation.

Tzivion G, Avruch J.

J Biol Chem. 2002 Feb 1;277(5):3061-4. Review. No abstract available.

20.
Items per page

Supplemental Content

Support Center